| Ages |
|
| <40 anos | 14 (11.02%) |
| 40 a 49 | 40 (31.49%) |
| 50 a 59 | 33 (25.98%) |
| 60 a 69 | 21 (16.53%) |
| >70 | 19 (14.96%) |
| Tumor subtypes | 86 |
| Luminal A | 15 (17.44%) |
| Luminal B | 18 (20.93%) |
| HER2+ Pure | 20 (23.25%) |
| Triplo negativo | 16 (18.60%) |
| Luminal-HER2 | 17 (19.76%) |
| Tumor size | 48 |
| T1 | 2 (4.16%) |
| T2 | 22 (45.83%) |
| T3 | 21 (43.75%) |
| T4 | 3 (6.25%) |
| Lymph nodes status | 48 |
| N0 | 19 (39.58%) |
| N1 | 18 (37.50%) |
| N2 | 10 (20.83%) |
| N3 | 1 (2.08%) |